AstraZeneca, Epizyme and Bristol-Myers Squibb to Lead 13th Compound and Management Summit

Add bookmark
Pharma IQ News
Pharma IQ News
07/13/2017

NEW YORK, NY, June 23, 2017: The 13th Compound & Sample Management Summit is pleased to return to Philadelphia, PA, on August 28-30, 2017, with an exciting new speaker faculty and discussion topics surrounding all new emerging industry trends. The highly-anticipated 3-day summit will bring together early drug discovery experts, coming from both big pharma and small, to discuss innovative solutions that will optimize compound labs and biobanks.This year, the summit will hone in on the specifi...
To continue reading this story get free access

RECOMMENDED